(3D) Bioprinting—Next Dimension of the Pharmaceutical Sector

(3D) Bioprinting—Next Dimension of the Pharmaceutical Sector

To create a review of the published scientific literature on the benefits and potential perspectives of the use of 3D bio-nitrification in the field of pharmaceutics. This work was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines...

Full description

Bibliographic Details
Main Authors: Anna Mihaylova, Dobromira Shopova, Nikoleta Parahuleva, Antoniya Yaneva, Desislava Bakova
Format: Article
Language:English
Published: MDPI AG 2024-06-01
Series:Pharmaceuticals
Subjects:
3D bioprinting
drug research and development
personalized medicine
pharmaceutical company
clinical trials
drug testing
Online Access:https://www.mdpi.com/1424-8247/17/6/797

Internet

https://www.mdpi.com/1424-8247/17/6/797

Similar Items